EUVIMEDEUVIMED entdecken
Crossref

Addressing Cluster‐Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs

Jiaqi Tong iD, Fan Li iD, Guangyu Tong iD

Biometrical Journal · 2026-06 · 68 (3)

DOI: 10.1002/bimj.70146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrical Journal, online erschienen am 15.06.2026. Verfasst von Jiaqi Tong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Biometry, Randomized Controlled Trials as Topic. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Patient-Centered Outcomes Research Institute Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A hierarchical factorial design is a type of two‐level trial design where the first intervention is randomized at the cluster level and the second intervention is randomized at the individual level. With a continuous outcome, the linear mixed model with a random intercept can be used for this design to estimate the treatment effects while accommodating the within‐cluster correlations. Such a model often serves as the basis for the sample size and power calculation. However, recent evidence in cluster randomized trials has shown that the cluster‐level intervention effect might differ across clusters, leading to extra variability in the outcomes. This paper extends the existing literature on designing hierarchical factorial trials to address heterogeneous treatment effects across clusters. Under the generalized least squares framework, we consider models with or without an interaction between the two interventions, and derive sample size formulas for testing the controlled effects, the marginal effects, and the interaction effect between the two treatments. Simulation studies were conducted to verify our sample size formulas in finite samples. The context of hierarchical factorial trial on suicide prevention is used for illustrating our methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiometryRandomized Controlled Trials as TopicSample SizeTreatment Effect HeterogeneityCluster AnalysisHumans

Stichwörter der Autor:innen

intracluster correlation coefficientlinear mixed modelspower analysisrandom slope modelsample size estimationsplit‐plot design

Autor:innen und Institutionen

  • Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
  • Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, Connecticut, USA.
  • Clinical and Translational Research Accelerator, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Cardiovascular Medicine Analytics Center, Yale School of Medicine, New Haven, Connecticut, USA.
  • Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Jiaqi Tong, Fan Li, Guangyu Tong

Förderung

  • Patient-Centered Outcomes Research Institute Award

Zitieren

APA

Tong, J., Li, F., & Tong, G. (2026). Addressing Cluster‐Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs. Biometrical Journal, 68(3). https://doi.org/10.1002/bimj.70146

Vancouver

Tong J, Li F, Tong G. Addressing Cluster‐Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs. Biometrical Journal. 2026;68(3). doi:10.1002/bimj.70146

BibTeX
@article{Tong2026,
  author = {Tong, Jiaqi and Li, Fan and Tong, Guangyu},
  title = {Addressing Cluster‐Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs},
  journal = {Biometrical Journal},
  year = {2026},
  volume = {68},
  number = {3},
  doi = {10.1002/bimj.70146}
}
Kostenlos starten →